Barinthus Biotherapeutics Plc (BRNS)
0.6807
0.00 (0.00%)
USD |
NASDAQ |
Jun 01, 16:00
Barinthus Biotherapeutics Shareholders Equity (Quarterly) : 66.40M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 605.69M |
| Autolus Therapeutics Plc | 108.83M |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Adaptimmune Therapeutics Plc | -70.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.14M |
| Total Liabilities (Quarterly) | 25.66M |
| Debt to Equity Ratio | 0.1658 |
| Current Ratio | 6.055 |
| Net Debt Paydown Yield | 0.86% |